Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Nicholson

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 21, 2013
Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitorMichitaka Yamaguchi, Mitsue Miyazaki, Matthew P Kodrasov, et al.
Journal of Natural Products|February 26, 2005
Lajollamycin, a nitro-tetraene spiro-beta-lactone-gamma-lactam antibiotic from the marine actinomycete Streptomyces nodosusRama Rao Manam, Sy Teisan, Donald J White, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47Joseph Weinstock, Jian Wu, Ping Cao, et al.
Journal of Cellular and Molecular Medicine|August 27, 2019
Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D acute myeloid leukaemia modelHaiyan Xu, Eric S Muise, Sarah Javaid, et al.
Protein Science : a Publication of the Protein Society|April 22, 2008
Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activitiesBenjamin Nicholson, Craig A Leach, Seth J Goldenberg, et al.
Cancer Cell|November 16, 2005
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from BortezomibDharminder Chauhan, Laurence Catley, Guilan Li, et al.
Journal for Immunotherapy of Cancer|January 2, 2024
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancerKurt A Jenkins, Miso Park, Magali Pederzoli-Ribeil, et al.
Journal of Medicinal Chemistry|May 27, 2005
Structure-activity relationship studies of salinosporamide A (NPI-0052), a novel marine derived proteasome inhibitorVenkat R Macherla, Scott S Mitchell, Rama Rao Manam, et al.
Cancer Cell|December 5, 2025
Tumor-initiating stem cells fine-tune the plasticity of neutrophils to sculpt a protective nicheWeijie Guo, Jingyun Luan, Xuejie Huang, et al.
Ebiomedicine|October 30, 2016
Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3+ T-regulatory Cell Function and Promotes Antitumor ImmunityLiqing Wang, Suresh Kumar, Satinder Dahiya, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|May 21, 2013
Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitorMichitaka Yamaguchi, Mitsue Miyazaki, Matthew P Kodrasov, et al.
Journal of Natural Products|February 26, 2005
Lajollamycin, a nitro-tetraene spiro-beta-lactone-gamma-lactam antibiotic from the marine actinomycete Streptomyces nodosusRama Rao Manam, Sy Teisan, Donald J White, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47Joseph Weinstock, Jian Wu, Ping Cao, et al.
Journal of Cellular and Molecular Medicine|August 27, 2019
Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D acute myeloid leukaemia modelHaiyan Xu, Eric S Muise, Sarah Javaid, et al.
Protein Science : a Publication of the Protein Society|April 22, 2008
Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activitiesBenjamin Nicholson, Craig A Leach, Seth J Goldenberg, et al.
Cancer Cell|November 16, 2005
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from BortezomibDharminder Chauhan, Laurence Catley, Guilan Li, et al.
Journal for Immunotherapy of Cancer|January 2, 2024
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancerKurt A Jenkins, Miso Park, Magali Pederzoli-Ribeil, et al.
Journal of Medicinal Chemistry|May 27, 2005
Structure-activity relationship studies of salinosporamide A (NPI-0052), a novel marine derived proteasome inhibitorVenkat R Macherla, Scott S Mitchell, Rama Rao Manam, et al.
Cancer Cell|December 5, 2025
Tumor-initiating stem cells fine-tune the plasticity of neutrophils to sculpt a protective nicheWeijie Guo, Jingyun Luan, Xuejie Huang, et al.
Ebiomedicine|October 30, 2016
Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3+ T-regulatory Cell Function and Promotes Antitumor ImmunityLiqing Wang, Suresh Kumar, Satinder Dahiya, et al.
Pageof 6